A biotechnology company won a preliminary injunction, partial summary judgment and a nearly $1 million sanctions award against its contract research organization in a breach-of-contract and conversion action. Our firm represented the biotech company in the victory.
.svg?rev=a492cc1069df46bdab38f8cb66573f1c&hash=2617C9FE8A7B0BD1C43269B5D5ED9AE2)
